enGene Holdings Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
enGene Holdings Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2022 to Q2 2024.
  • enGene Holdings Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was $2.58M, a 69% increase year-over-year.
  • enGene Holdings Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was -$67.1M.
  • enGene Holdings Inc. annual Nonoperating Income (Expense) for 2023 was -$73.8M, a 1373% decline from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$67.1M $2.58M +$1.05M +69% May 1, 2024 Jul 31, 2024 10-Q 2024-09-10
Q1 2024 -$68.1M $2.35M +$2.89M Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$71M $32K +$2.82M Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$73.8M -$72M Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $1.53M May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 -$545K Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$2.79M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.